Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc.（ELVN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
elvn · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$80.00
Consensus
$67.00
+95.8% upside
Low
$59.00
Median: $62 · Last Close: $34.21
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$67.00
95.8% upside
High Target
$80
133.8%
Low Target
$59
72.5%
Current Price
$34.21
as of today
Based on analyst price targets, the ELVN stock price prediction for the next 12 months ranges from $59 to $80. The consensus ELVN price forecast of $67.00 implies 95.8% upside from the current price of $34.21.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $32.50 | ↓ 5.00% |
1-day model range: $32.33–$32.67. Peak: $32.67 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ELVN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-08 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-25 | Mizuho | Maintains | Outperform→Outperform |
| 2025-07-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-16 | Baird | Maintains | Outperform→Outperform |
| 2025-05-16 | Jones Trading | Maintains | Buy→Buy |
| 2025-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-15 | Baird | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Enliven Therapeutics, Inc. (ELVN) stock. Of the recent 13 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover ELVN.
分析师推荐趋势
ELVN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 40.0% YoY
Revenue Next Year
$0M
↓ 16.7% YoY
EPS This Year
$-1.75
EPS Next Year
$-2.38
↑ 36.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ELVN EPS of $-1.75 for the current fiscal year, based on estimates from 4 analysts. The ELVN revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ELVN 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ELVN 的共识目标价为 $67.00（+95.8% 上行空间），分析师共识为 Buy。
ELVN 的短期预测（明日）为 $32.50（-5.00%）。
Enliven Therapeutics, Inc. 在 NASDAQ 上市，代码 ELVN。ELVN 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
ELVN 预测 · 8 个问题根据 7 位华尔街分析师，ELVN 的 12 个月平均目标价为 $67.00，最高 $80.00、最低 $59.00。若有图表，中位目标价可在上方查看。相对当前价 $34.21，隐含约 +95.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.